| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |